Woven Orthopedic Technologies

Woven Orthopedic Technologies

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $10M

Overview

Woven Orthopedic Technologies addresses a critical and common challenge in orthopedic surgery: achieving stable screw fixation in compromised bone. The company's flagship product, the Ogmend® Implant Enhancement System, is an off-the-shelf, implantable sleeve that enhances the stability between screws and bone, aiming to improve surgical outcomes, reduce procedure time, and lower costs. Founded by a surgeon who experienced the clinical need firsthand, Woven is a private, commercial-stage company targeting a significant global market for orthopedic fixation augmentation. Its value proposition centers on providing a simple, reliable solution for complex fixation scenarios where traditional hardware may fail.

OrthopedicsSpine Surgery

Technology Platform

The Ogmend® Implant Enhancement System, an implantable sleeve that acts as a wall anchor to enhance screw fixation stability in compromised bone.

Funding History

2
Total raised:$10M
Series A$8M
Seed$2M

Opportunities

The aging global population and rising rates of osteoporosis create a growing patient base with compromised bone quality, increasing the need for enhanced fixation solutions.
The product's simplicity and compatibility with existing hardware allow it to address a cross-platform need in trauma, spine, and joint reconstruction, representing a large total addressable market.

Risk Factors

Commercial success depends on convincing surgeons to change practice and adopt a new ancillary product in a market dominated by large, established competitors.
Securing adequate insurance reimbursement and hospital budget approval is a critical and non-trivial hurdle to widespread adoption.

Competitive Landscape

Woven competes indirectly with all major orthopedic implant companies (e.g., Stryker, Johnson & Johnson, Zimmer Biomet) whose core screw systems it aims to augment. Direct competition may come from other bone augmentation technologies (e.g., bone cements, expandable screws) and from potential future me-too products launched by large incumbents if the market proves attractive.